{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-014894","form_type":"8-K","ticker":"MLTX","cik":"0001821586","company_name":"MoonLake Immunotherapeutics","filed_at":"2022-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.501906+00:00","generated_at":"2026-06-26T18:44:54.061284+00:00","sec_items":["2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Helix Acquisition Corp. receives $150,000 working capital loan from affiliate Cormorant Asset Management","bullets":["Cormorant Asset Management LP, an affiliate of Helix officers, loaned $150,000 for working capital.","Loan is non-interest bearing, non-convertible, payable upon consummation of a business combination.","If no business combination occurs, the loan is forgiven except for funds available outside trust account.","Helix is pursuing a business combination with MoonLake Immunotherapeutics AG as previously disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-014894","json":"https://secwatch.observer/filing/0001213900-22-014894.json","markdown":"https://secwatch.observer/filing/0001213900-22-014894.md","text":"https://secwatch.observer/filing/0001213900-22-014894.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1821586/000121390022014894/0001213900-22-014894-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1821586/000121390022014894/ea157366-8k425_helix.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T18:44:54.061284+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}